These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16583564)

  • 21. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 22. [A review of selected cytostatic agents based on platinum].
    Hejl J; Kiss F; Hejlová N
    Vnitr Lek; 1985 Jun; 31(6):577-84. PubMed ID: 3898566
    [No Abstract]   [Full Text] [Related]  

  • 23. [ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment].
    de la Haba-Rodríguez JR; Ortiz-Morales MJ; Gómez-España MA; Aranda Aguilar E
    Med Clin (Barc); 2012 Apr; 138(10):456-7. PubMed ID: 21982686
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of sulfur in platinum anticancer chemotherapy.
    Wang And X; Guo Z
    Anticancer Agents Med Chem; 2007 Jan; 7(1):19-34. PubMed ID: 17266503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New platinum antitumor complexes.
    Kelland LR
    Crit Rev Oncol Hematol; 1993 Dec; 15(3):191-219. PubMed ID: 8142057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Satraplatin: an orally available platinum analog for the treatment of cancer.
    Choy H
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):973-82. PubMed ID: 16831070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platinum compounds in children with cancer: toxicity and clinical management.
    Ruggiero A; Trombatore G; Triarico S; Arena R; Ferrara P; Scalzone M; Pierri F; Riccardi R
    Anticancer Drugs; 2013 Nov; 24(10):1007-19. PubMed ID: 23962902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxaliplatin-induced Evan's syndrome.
    Earle CC; Chen WY; Ryan DP; Mayer RJ
    Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
    [No Abstract]   [Full Text] [Related]  

  • 29. Carboplatin.
    Med Lett Drugs Ther; 1989 Sep; 31(800):83-4. PubMed ID: 2671623
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxicities of the platinum antineoplastic agents.
    Markman M
    Expert Opin Drug Saf; 2003 Nov; 2(6):597-607. PubMed ID: 14585068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs.
    Ensslin AS; Pethran A; Schierl R; Fruhmann G
    Int Arch Occup Environ Health; 1994; 65(5):339-42. PubMed ID: 8175190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of carboplatin in non-small cell lung cancer.
    Olver IN; Donehower RC; Van Echo DA; Ettinger DS; Aisner J
    Cancer Treat Rep; 1986 Mar; 70(3):421-2. PubMed ID: 3513947
    [No Abstract]   [Full Text] [Related]  

  • 33. Potential for platinum analogs in the treatment of cancer of the uterine cervix.
    Muggia FM; Lira-Puerto V; Carugati A; Pavlovsky S
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():93-9. PubMed ID: 3910226
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-classical structures among current platinum complexes with potential as antitumor drugs.
    G Quiroga A
    Curr Top Med Chem; 2011; 11(21):2613-22. PubMed ID: 22039872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xaliproden lessens oxaliplatin-mediated neuropathy.
    Susman E
    Lancet Oncol; 2006 Apr; 7(4):288. PubMed ID: 16598880
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Bhargava P; Gammon D; McCormick MJ
    Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe anaphylactic reaction to oxaliplatin.
    Alliot C; Messouak D; Beets C; Rapin JP
    Clin Oncol (R Coll Radiol); 2001; 13(3):236. PubMed ID: 11527302
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase I study and pharmacokinetics of intraperitoneal carboplatin.
    McVie JG; ten Bokkel Huinink W; Dubbelman R; Franklin H; van der Vijgh W; Klein I
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():35-41. PubMed ID: 3910220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboplatin: the clinical spectrum to date.
    Canetta R; Rozencweig M; Carter SK
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():125-36. PubMed ID: 3002623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytostatic drugs. 1: Platinum compounds, alkylating and intercalating cytostatic drugs].
    Bauch HJ
    Med Monatsschr Pharm; 1989 Jan; 12(1):8-20. PubMed ID: 2643766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.